image

The best stocks to buy since 1993

Latest issue now available

Alliance Pharma

February 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • APH
  • Price:
  • 64p
Alliance’s preclose trading update said sales in 2018 were up 22% at £124m (4% organic).The International Star brands continued to perform strongly in 2018: Kelo-kote (+68% to £22.5m), MacuShield (+ 6% at £7.0m) and  Vamousse (+16% at £5.8m). Nizoral made a maiden contribution of £10.9m under its transitional services agreement with J&J and Xonvea has only been recently launched in October.Sales of Local Brands were £77.8m, down 5% but with a stronger exit trading. Await the results due on 26 March. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe